|
ATCC
m simiae atcc 25275 M Simiae Atcc 25275, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/m simiae atcc 25275/product/ATCC Average 94 stars, based on 1 article reviews
m simiae atcc 25275 - by Bioz Stars,
2026-02
94/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
rabaptin 5 Rabaptin 5, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/rabaptin 5/product/Santa Cruz Biotechnology Average 93 stars, based on 1 article reviews
rabaptin 5 - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
|
Proteintech
uroplakin 1a  Uroplakin 1a, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/uroplakin 1a/product/Proteintech Average 93 stars, based on 1 article reviews
uroplakin 1a - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Stem Cells International
Article Title: Therapeutic Effects of Human Urine-Derived Stem Cells in a Rat Model of Cisplatin-Induced Acute Kidney Injury In Vivo and In Vitro
doi: 10.1155/2019/8035076
Figure Lengend Snippet: Multipotential differentiation of USCs. (a) SMC-differentiated cells showed an increased expression of the SMC-specific markers desmin, myosin, ASMA, and vimentin. (b) The UC-differentiated cells showed an increased expression of the UC-specific markers UP-Ia, UP-III, AE1/AE3, and CK13. NC: negative control; ASMA: alpha-smooth muscle actin; UP-Ia: uroplakin 1A; UP-III: uroplakin 3; AE1/AE3: cytokeratin, clone AE1/AE3; CK13: cytokeratin 13. Scale bar: 25 μ m.
Article Snippet: USCs were assessed for the expression of the stem cell surface markers CD31 (Cell Signaling Technology, 3528), CD34 (Proteintech, 14486-1-AP), CD45 (Cell Signaling Technology, 13917), CD44 (Abcam, ab46793), CD133 (Proteintech, 18470-1-AP), SSEA4 (Proteintech, 19497-1-AP), CD146 (Proteintech, 17564-1-AP), platelet-derived growth factor beta-receptor (PDGFRB, Proteintech, 13449-1-AP), and neural/glial antigen 2 (NG2, Abcam, ab129051), and the SMC- or UC-induced USCs were evaluated for the SMC or UC surface marker desmin (Abcam, ab32362), myosin (Proteintech, 20716-1-AP), alpha-smooth muscle actin (ASMA, Proteintech, 23660-1-AP), vimentin (Proteintech, 10366-1-AP), or
Techniques: Expressing, Negative Control